Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-002188-13Phase 4Completed
Phase 4, randomised, open-label trial in status epilepticus (SE) comparing Intravenous levetiracetam with Intravenous phenytoin (2 arms). Primary endpoint: Time to cessation of convulsive seizure activity. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-002188-13.